nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—SLC12A1—urine—prostate cancer	0.0253	0.113	CbGeAlD
Hydroflumethiazide—CA14—prostate gland—prostate cancer	0.0101	0.0454	CbGeAlD
Hydroflumethiazide—SLC12A1—prostate gland—prostate cancer	0.00907	0.0407	CbGeAlD
Hydroflumethiazide—CA14—seminal vesicle—prostate cancer	0.00855	0.0384	CbGeAlD
Hydroflumethiazide—CA7—renal system—prostate cancer	0.00827	0.0371	CbGeAlD
Hydroflumethiazide—KCNMA1—prostate gland—prostate cancer	0.00822	0.0369	CbGeAlD
Hydroflumethiazide—SLC12A3—renal system—prostate cancer	0.0081	0.0364	CbGeAlD
Hydroflumethiazide—CA5B—prostate gland—prostate cancer	0.00707	0.0317	CbGeAlD
Hydroflumethiazide—SLC12A1—epithelium—prostate cancer	0.00667	0.0299	CbGeAlD
Hydroflumethiazide—SLC12A1—renal system—prostate cancer	0.00618	0.0278	CbGeAlD
Hydroflumethiazide—SLC12A1—urethra—prostate cancer	0.00607	0.0273	CbGeAlD
Hydroflumethiazide—KCNMA1—epithelium—prostate cancer	0.00604	0.0271	CbGeAlD
Hydroflumethiazide—KCNMA1—renal system—prostate cancer	0.0056	0.0251	CbGeAlD
Hydroflumethiazide—CA12—renal system—prostate cancer	0.00537	0.0241	CbGeAlD
Hydroflumethiazide—ATP1A1—prostate gland—prostate cancer	0.00528	0.0237	CbGeAlD
Hydroflumethiazide—CA4—prostate gland—prostate cancer	0.00488	0.0219	CbGeAlD
Hydroflumethiazide—CA5B—urethra—prostate cancer	0.00473	0.0212	CbGeAlD
Hydroflumethiazide—CA9—testis—prostate cancer	0.00469	0.0211	CbGeAlD
Hydroflumethiazide—ATP1A1—seminal vesicle—prostate cancer	0.00447	0.02	CbGeAlD
Hydroflumethiazide—CA1—renal system—prostate cancer	0.00426	0.0191	CbGeAlD
Hydroflumethiazide—CA4—seminal vesicle—prostate cancer	0.00413	0.0185	CbGeAlD
Hydroflumethiazide—CA2—prostate gland—prostate cancer	0.00405	0.0182	CbGeAlD
Hydroflumethiazide—SLC12A1—testis—prostate cancer	0.004	0.0179	CbGeAlD
Hydroflumethiazide—ATP1A1—epithelium—prostate cancer	0.00388	0.0174	CbGeAlD
Hydroflumethiazide—KCNMA1—testis—prostate cancer	0.00362	0.0163	CbGeAlD
Hydroflumethiazide—ATP1A1—renal system—prostate cancer	0.0036	0.0162	CbGeAlD
Hydroflumethiazide—ATP1A1—urethra—prostate cancer	0.00354	0.0159	CbGeAlD
Hydroflumethiazide—CA2—seminal vesicle—prostate cancer	0.00342	0.0154	CbGeAlD
Hydroflumethiazide—CA4—renal system—prostate cancer	0.00333	0.0149	CbGeAlD
Hydroflumethiazide—CA4—urethra—prostate cancer	0.00327	0.0147	CbGeAlD
Hydroflumethiazide—CA1—bone marrow—prostate cancer	0.00322	0.0144	CbGeAlD
Hydroflumethiazide—CA5B—testis—prostate cancer	0.00311	0.014	CbGeAlD
Hydroflumethiazide—CA2—epithelium—prostate cancer	0.00297	0.0133	CbGeAlD
Hydroflumethiazide—CA2—renal system—prostate cancer	0.00276	0.0124	CbGeAlD
Hydroflumethiazide—ATP1A1—bone marrow—prostate cancer	0.00272	0.0122	CbGeAlD
Hydroflumethiazide—KCNMA1—lymph node—prostate cancer	0.00262	0.0118	CbGeAlD
Hydroflumethiazide—CA4—bone marrow—prostate cancer	0.00251	0.0113	CbGeAlD
Hydroflumethiazide—ATP1A1—testis—prostate cancer	0.00233	0.0104	CbGeAlD
Hydroflumethiazide—CA5B—lymph node—prostate cancer	0.00226	0.0101	CbGeAlD
Hydroflumethiazide—CA4—testis—prostate cancer	0.00215	0.00965	CbGeAlD
Hydroflumethiazide—CA2—bone marrow—prostate cancer	0.00209	0.00936	CbGeAlD
Hydroflumethiazide—CA1—lymph node—prostate cancer	0.00199	0.00895	CbGeAlD
Hydroflumethiazide—CA2—testis—prostate cancer	0.00178	0.008	CbGeAlD
Hydroflumethiazide—ATP1A1—lymph node—prostate cancer	0.00169	0.00757	CbGeAlD
Hydroflumethiazide—CA4—lymph node—prostate cancer	0.00156	0.007	CbGeAlD
Hydroflumethiazide—Asthenia—Cabazitaxel—prostate cancer	0.00135	0.00288	CcSEcCtD
Hydroflumethiazide—Glycosuria—Epirubicin—prostate cancer	0.00134	0.00286	CcSEcCtD
Hydroflumethiazide—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00134	0.00285	CcSEcCtD
Hydroflumethiazide—Nausea—Nilutamide—prostate cancer	0.00133	0.00283	CcSEcCtD
Hydroflumethiazide—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00133	0.00283	CcSEcCtD
Hydroflumethiazide—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00133	0.00282	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Goserelin—prostate cancer	0.00133	0.00282	CcSEcCtD
Hydroflumethiazide—Nausea—Flutamide—prostate cancer	0.00133	0.00282	CcSEcCtD
Hydroflumethiazide—Dizziness—Degarelix—prostate cancer	0.00132	0.00282	CcSEcCtD
Hydroflumethiazide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00132	0.00281	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Mitoxantrone—prostate cancer	0.00132	0.00281	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Conjugated Estrogens—prostate cancer	0.00131	0.0028	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—prostate cancer	0.00129	0.0058	CbGeAlD
Hydroflumethiazide—Diarrhoea—Cabazitaxel—prostate cancer	0.00129	0.00275	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Capecitabine—prostate cancer	0.00129	0.00275	CcSEcCtD
Hydroflumethiazide—Urticaria—Bicalutamide—prostate cancer	0.00129	0.00274	CcSEcCtD
Hydroflumethiazide—Vomiting—Degarelix—prostate cancer	0.00127	0.00271	CcSEcCtD
Hydroflumethiazide—Jaundice—Mitoxantrone—prostate cancer	0.00127	0.00271	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Etoposide—prostate cancer	0.00127	0.0027	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Capecitabine—prostate cancer	0.00127	0.00269	CcSEcCtD
Hydroflumethiazide—Rash—Degarelix—prostate cancer	0.00126	0.00269	CcSEcCtD
Hydroflumethiazide—Dermatitis—Degarelix—prostate cancer	0.00126	0.00269	CcSEcCtD
Hydroflumethiazide—Headache—Degarelix—prostate cancer	0.00125	0.00267	CcSEcCtD
Hydroflumethiazide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00125	0.00266	CcSEcCtD
Hydroflumethiazide—Dizziness—Cabazitaxel—prostate cancer	0.00125	0.00266	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—prostate cancer	0.00124	0.00264	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—prostate cancer	0.00124	0.00263	CcSEcCtD
Hydroflumethiazide—Leukopenia—Goserelin—prostate cancer	0.00123	0.00263	CcSEcCtD
Hydroflumethiazide—Vertigo—Conjugated Estrogens—prostate cancer	0.00123	0.00261	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Mitoxantrone—prostate cancer	0.00122	0.00259	CcSEcCtD
Hydroflumethiazide—Vomiting—Cabazitaxel—prostate cancer	0.0012	0.00255	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Bicalutamide—prostate cancer	0.00119	0.00254	CcSEcCtD
Hydroflumethiazide—Nausea—Degarelix—prostate cancer	0.00119	0.00253	CcSEcCtD
Hydroflumethiazide—Headache—Cabazitaxel—prostate cancer	0.00118	0.00252	CcSEcCtD
Hydroflumethiazide—Purpura—Capecitabine—prostate cancer	0.00117	0.0025	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—prostate cancer	0.00117	0.00249	CcSEcCtD
Hydroflumethiazide—Constipation—Ethinyl Estradiol—prostate cancer	0.00117	0.00249	CcSEcCtD
Hydroflumethiazide—Asthenia—Bicalutamide—prostate cancer	0.00116	0.00247	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—prostate cancer	0.00114	0.00244	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Prednisone—prostate cancer	0.00113	0.0024	CcSEcCtD
Hydroflumethiazide—Nausea—Cabazitaxel—prostate cancer	0.00112	0.00239	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Bicalutamide—prostate cancer	0.00111	0.00236	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—prostate cancer	0.00111	0.00236	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Goserelin—prostate cancer	0.0011	0.00235	CcSEcCtD
Hydroflumethiazide—Urticaria—Ethinyl Estradiol—prostate cancer	0.00109	0.00231	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—prostate cancer	0.00108	0.00231	CcSEcCtD
Hydroflumethiazide—Anorexia—Goserelin—prostate cancer	0.00107	0.00228	CcSEcCtD
Hydroflumethiazide—Dizziness—Bicalutamide—prostate cancer	0.00107	0.00228	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Docetaxel—prostate cancer	0.00107	0.00227	CcSEcCtD
Hydroflumethiazide—Anorexia—Conjugated Estrogens—prostate cancer	0.00106	0.00226	CcSEcCtD
Hydroflumethiazide—Jaundice—Etoposide—prostate cancer	0.00106	0.00225	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Docetaxel—prostate cancer	0.00105	0.00224	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Estradiol—prostate cancer	0.00105	0.00224	CcSEcCtD
Hydroflumethiazide—Purpura—Prednisone—prostate cancer	0.00105	0.00223	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Capecitabine—prostate cancer	0.00103	0.0022	CcSEcCtD
Hydroflumethiazide—Vomiting—Bicalutamide—prostate cancer	0.00103	0.00219	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—prostate cancer	0.00102	0.00218	CcSEcCtD
Hydroflumethiazide—Rash—Bicalutamide—prostate cancer	0.00102	0.00217	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—prostate cancer	0.00102	0.00217	CcSEcCtD
Hydroflumethiazide—Dermatitis—Bicalutamide—prostate cancer	0.00102	0.00217	CcSEcCtD
Hydroflumethiazide—Headache—Bicalutamide—prostate cancer	0.00101	0.00216	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Etoposide—prostate cancer	0.00101	0.00215	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00101	0.00215	CcSEcCtD
Hydroflumethiazide—Agitation—Estradiol—prostate cancer	0.001	0.00214	CcSEcCtD
Hydroflumethiazide—Vertigo—Estradiol—prostate cancer	0.000982	0.00209	CcSEcCtD
Hydroflumethiazide—Asthenia—Ethinyl Estradiol—prostate cancer	0.000981	0.00209	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Goserelin—prostate cancer	0.000978	0.00208	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000969	0.00206	CcSEcCtD
Hydroflumethiazide—Constipation—Goserelin—prostate cancer	0.000962	0.00205	CcSEcCtD
Hydroflumethiazide—Nausea—Bicalutamide—prostate cancer	0.000961	0.00205	CcSEcCtD
Hydroflumethiazide—Constipation—Conjugated Estrogens—prostate cancer	0.000953	0.00203	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—prostate cancer	0.000944	0.00201	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000936	0.00199	CcSEcCtD
Hydroflumethiazide—Leukopenia—Mitoxantrone—prostate cancer	0.000912	0.00194	CcSEcCtD
Hydroflumethiazide—Dizziness—Ethinyl Estradiol—prostate cancer	0.000904	0.00193	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—prostate cancer	0.000898	0.00191	CcSEcCtD
Hydroflumethiazide—Urticaria—Goserelin—prostate cancer	0.000894	0.0019	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Capecitabine—prostate cancer	0.000893	0.0019	CcSEcCtD
Hydroflumethiazide—Urticaria—Conjugated Estrogens—prostate cancer	0.000886	0.00189	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Capecitabine—prostate cancer	0.000883	0.00188	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—prostate cancer	0.000882	0.00188	CcSEcCtD
Hydroflumethiazide—Jaundice—Docetaxel—prostate cancer	0.000878	0.00187	CcSEcCtD
Hydroflumethiazide—Vomiting—Ethinyl Estradiol—prostate cancer	0.00087	0.00185	CcSEcCtD
Hydroflumethiazide—Rash—Ethinyl Estradiol—prostate cancer	0.000862	0.00184	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000861	0.00183	CcSEcCtD
Hydroflumethiazide—Headache—Ethinyl Estradiol—prostate cancer	0.000857	0.00182	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Prednisone—prostate cancer	0.000855	0.00182	CcSEcCtD
Hydroflumethiazide—Jaundice—Capecitabine—prostate cancer	0.00085	0.00181	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Docetaxel—prostate cancer	0.000841	0.00179	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—prostate cancer	0.000831	0.00177	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Goserelin—prostate cancer	0.000829	0.00177	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000821	0.00175	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—prostate cancer	0.000818	0.00174	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—prostate cancer	0.000816	0.00174	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—prostate cancer	0.000815	0.00173	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Capecitabine—prostate cancer	0.000814	0.00173	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000814	0.00173	CcSEcCtD
Hydroflumethiazide—Nausea—Ethinyl Estradiol—prostate cancer	0.000812	0.00173	CcSEcCtD
Hydroflumethiazide—Asthenia—Goserelin—prostate cancer	0.000808	0.00172	CcSEcCtD
Hydroflumethiazide—Asthenia—Conjugated Estrogens—prostate cancer	0.0008	0.0017	CcSEcCtD
Hydroflumethiazide—Anorexia—Mitoxantrone—prostate cancer	0.000792	0.00169	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Prednisone—prostate cancer	0.000786	0.00167	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Estradiol—prostate cancer	0.000776	0.00165	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Goserelin—prostate cancer	0.00077	0.00164	CcSEcCtD
Hydroflumethiazide—Constipation—Estradiol—prostate cancer	0.000763	0.00162	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000763	0.00162	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—prostate cancer	0.000761	0.00162	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—prostate cancer	0.000758	0.00162	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—prostate cancer	0.000757	0.00161	CcSEcCtD
Hydroflumethiazide—Dizziness—Goserelin—prostate cancer	0.000744	0.00158	CcSEcCtD
Hydroflumethiazide—Dizziness—Conjugated Estrogens—prostate cancer	0.000737	0.00157	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Mitoxantrone—prostate cancer	0.000723	0.00154	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—prostate cancer	0.00072	0.00153	CcSEcCtD
Hydroflumethiazide—Vomiting—Goserelin—prostate cancer	0.000716	0.00152	CcSEcCtD
Hydroflumethiazide—Constipation—Mitoxantrone—prostate cancer	0.000711	0.00151	CcSEcCtD
Hydroflumethiazide—Rash—Goserelin—prostate cancer	0.00071	0.00151	CcSEcCtD
Hydroflumethiazide—Dermatitis—Goserelin—prostate cancer	0.000709	0.00151	CcSEcCtD
Hydroflumethiazide—Vomiting—Conjugated Estrogens—prostate cancer	0.000709	0.00151	CcSEcCtD
Hydroflumethiazide—Urticaria—Estradiol—prostate cancer	0.000709	0.00151	CcSEcCtD
Hydroflumethiazide—Headache—Goserelin—prostate cancer	0.000705	0.0015	CcSEcCtD
Hydroflumethiazide—Rash—Conjugated Estrogens—prostate cancer	0.000703	0.0015	CcSEcCtD
Hydroflumethiazide—Dermatitis—Conjugated Estrogens—prostate cancer	0.000702	0.0015	CcSEcCtD
Hydroflumethiazide—Headache—Conjugated Estrogens—prostate cancer	0.000698	0.00149	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Etoposide—prostate cancer	0.000677	0.00144	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Docetaxel—prostate cancer	0.000677	0.00144	CcSEcCtD
Hydroflumethiazide—Nausea—Goserelin—prostate cancer	0.000669	0.00142	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—prostate cancer	0.000668	0.00142	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000666	0.00142	CcSEcCtD
Hydroflumethiazide—Nausea—Conjugated Estrogens—prostate cancer	0.000662	0.00141	CcSEcCtD
Hydroflumethiazide—Urticaria—Mitoxantrone—prostate cancer	0.00066	0.00141	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—prostate cancer	0.000659	0.0014	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Estradiol—prostate cancer	0.000657	0.0014	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Capecitabine—prostate cancer	0.000655	0.0014	CcSEcCtD
Hydroflumethiazide—Asthenia—Estradiol—prostate cancer	0.00064	0.00136	CcSEcCtD
Hydroflumethiazide—Leukopenia—Docetaxel—prostate cancer	0.00063	0.00134	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—prostate cancer	0.000622	0.00132	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—prostate cancer	0.000618	0.00132	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—prostate cancer	0.000615	0.00131	CcSEcCtD
Hydroflumethiazide—Vertigo—Capecitabine—prostate cancer	0.000613	0.0013	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Mitoxantrone—prostate cancer	0.000613	0.0013	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Estradiol—prostate cancer	0.00061	0.0013	CcSEcCtD
Hydroflumethiazide—Leukopenia—Capecitabine—prostate cancer	0.00061	0.0013	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—prostate cancer	0.000601	0.00128	CcSEcCtD
Hydroflumethiazide—Asthenia—Mitoxantrone—prostate cancer	0.000596	0.00127	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—prostate cancer	0.000592	0.00126	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—prostate cancer	0.000591	0.00126	CcSEcCtD
Hydroflumethiazide—Dizziness—Estradiol—prostate cancer	0.00059	0.00126	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000576	0.00123	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—prostate cancer	0.000569	0.00121	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Mitoxantrone—prostate cancer	0.000569	0.00121	CcSEcCtD
Hydroflumethiazide—Vomiting—Estradiol—prostate cancer	0.000567	0.00121	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—prostate cancer	0.000567	0.00121	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Docetaxel—prostate cancer	0.000563	0.0012	CcSEcCtD
Hydroflumethiazide—Rash—Estradiol—prostate cancer	0.000563	0.0012	CcSEcCtD
Hydroflumethiazide—Dermatitis—Estradiol—prostate cancer	0.000562	0.0012	CcSEcCtD
Hydroflumethiazide—Headache—Estradiol—prostate cancer	0.000559	0.00119	CcSEcCtD
Hydroflumethiazide—Agitation—Prednisone—prostate cancer	0.000558	0.00119	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—prostate cancer	0.000549	0.00117	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—prostate cancer	0.000548	0.00117	CcSEcCtD
Hydroflumethiazide—Anorexia—Docetaxel—prostate cancer	0.000548	0.00117	CcSEcCtD
Hydroflumethiazide—Vertigo—Prednisone—prostate cancer	0.000546	0.00116	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Capecitabine—prostate cancer	0.000545	0.00116	CcSEcCtD
Hydroflumethiazide—Anorexia—Capecitabine—prostate cancer	0.00053	0.00113	CcSEcCtD
Hydroflumethiazide—Nausea—Estradiol—prostate cancer	0.00053	0.00113	CcSEcCtD
Hydroflumethiazide—Vomiting—Mitoxantrone—prostate cancer	0.000529	0.00113	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—prostate cancer	0.000525	0.00112	CcSEcCtD
Hydroflumethiazide—Rash—Mitoxantrone—prostate cancer	0.000524	0.00112	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mitoxantrone—prostate cancer	0.000524	0.00112	CcSEcCtD
Hydroflumethiazide—Headache—Mitoxantrone—prostate cancer	0.000521	0.00111	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—prostate cancer	0.000509	0.00108	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Docetaxel—prostate cancer	0.0005	0.00106	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—prostate cancer	0.000496	0.00106	CcSEcCtD
Hydroflumethiazide—Nausea—Mitoxantrone—prostate cancer	0.000494	0.00105	CcSEcCtD
Hydroflumethiazide—Constipation—Docetaxel—prostate cancer	0.000491	0.00105	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Capecitabine—prostate cancer	0.000484	0.00103	CcSEcCtD
Hydroflumethiazide—Constipation—Capecitabine—prostate cancer	0.000476	0.00101	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—prostate cancer	0.000473	0.00101	CcSEcCtD
Hydroflumethiazide—Anorexia—Prednisone—prostate cancer	0.000472	0.00101	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—prostate cancer	0.000457	0.000974	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—prostate cancer	0.000457	0.000972	CcSEcCtD
Hydroflumethiazide—Urticaria—Capecitabine—prostate cancer	0.000442	0.000941	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—prostate cancer	0.00044	0.000936	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—prostate cancer	0.000436	0.000929	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—prostate cancer	0.000436	0.000929	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—prostate cancer	0.000436	0.000928	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—prostate cancer	0.000433	0.000923	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Prednisone—prostate cancer	0.000431	0.000917	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—prostate cancer	0.000427	0.000909	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—prostate cancer	0.000425	0.000905	CcSEcCtD
Hydroflumethiazide—Constipation—Prednisone—prostate cancer	0.000424	0.000903	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Docetaxel—prostate cancer	0.000423	0.000902	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—prostate cancer	0.000423	0.0009	CcSEcCtD
Hydroflumethiazide—Asthenia—Docetaxel—prostate cancer	0.000412	0.000878	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—prostate cancer	0.000411	0.000875	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Capecitabine—prostate cancer	0.00041	0.000873	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—prostate cancer	0.000404	0.00086	CcSEcCtD
Hydroflumethiazide—Asthenia—Capecitabine—prostate cancer	0.000399	0.00085	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—prostate cancer	0.000395	0.000841	CcSEcCtD
Hydroflumethiazide—Urticaria—Prednisone—prostate cancer	0.000394	0.000838	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—prostate cancer	0.000393	0.000838	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Docetaxel—prostate cancer	0.000393	0.000837	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Capecitabine—prostate cancer	0.000381	0.000811	CcSEcCtD
Hydroflumethiazide—Dizziness—Docetaxel—prostate cancer	0.00038	0.000809	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—prostate cancer	0.00038	0.000808	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—prostate cancer	0.000369	0.000787	CcSEcCtD
Hydroflumethiazide—Dizziness—Capecitabine—prostate cancer	0.000368	0.000784	CcSEcCtD
Hydroflumethiazide—Vomiting—Docetaxel—prostate cancer	0.000365	0.000778	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Prednisone—prostate cancer	0.000365	0.000778	CcSEcCtD
Hydroflumethiazide—Rash—Docetaxel—prostate cancer	0.000362	0.000772	CcSEcCtD
Hydroflumethiazide—Dermatitis—Docetaxel—prostate cancer	0.000362	0.000771	CcSEcCtD
Hydroflumethiazide—Headache—Docetaxel—prostate cancer	0.00036	0.000767	CcSEcCtD
Hydroflumethiazide—Asthenia—Prednisone—prostate cancer	0.000356	0.000757	CcSEcCtD
Hydroflumethiazide—Vomiting—Capecitabine—prostate cancer	0.000354	0.000753	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000351	0.000748	CcSEcCtD
Hydroflumethiazide—Rash—Capecitabine—prostate cancer	0.000351	0.000747	CcSEcCtD
Hydroflumethiazide—Dermatitis—Capecitabine—prostate cancer	0.000351	0.000746	CcSEcCtD
Hydroflumethiazide—Headache—Capecitabine—prostate cancer	0.000349	0.000742	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—prostate cancer	0.000342	0.000728	CcSEcCtD
Hydroflumethiazide—Nausea—Docetaxel—prostate cancer	0.000341	0.000727	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Prednisone—prostate cancer	0.000339	0.000722	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—prostate cancer	0.000337	0.000718	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—prostate cancer	0.000331	0.000706	CcSEcCtD
Hydroflumethiazide—Nausea—Capecitabine—prostate cancer	0.000331	0.000704	CcSEcCtD
Hydroflumethiazide—Dizziness—Prednisone—prostate cancer	0.000328	0.000698	CcSEcCtD
Hydroflumethiazide—Vomiting—Prednisone—prostate cancer	0.000315	0.000671	CcSEcCtD
Hydroflumethiazide—Rash—Prednisone—prostate cancer	0.000312	0.000665	CcSEcCtD
Hydroflumethiazide—Dermatitis—Prednisone—prostate cancer	0.000312	0.000665	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—prostate cancer	0.000312	0.000664	CcSEcCtD
Hydroflumethiazide—Headache—Prednisone—prostate cancer	0.00031	0.000661	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—prostate cancer	0.000308	0.000656	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—prostate cancer	0.000307	0.000653	CcSEcCtD
Hydroflumethiazide—Nausea—Prednisone—prostate cancer	0.000294	0.000627	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—prostate cancer	0.000286	0.000608	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—prostate cancer	0.000285	0.000607	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—prostate cancer	0.000278	0.000592	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—prostate cancer	0.000265	0.000565	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—prostate cancer	0.000264	0.000563	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—prostate cancer	0.000257	0.000548	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—prostate cancer	0.000256	0.000546	CcSEcCtD
Hydroflumethiazide—Vomiting—Epirubicin—prostate cancer	0.000246	0.000525	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—prostate cancer	0.000245	0.000523	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—prostate cancer	0.000244	0.00052	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—prostate cancer	0.000244	0.00052	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—prostate cancer	0.000243	0.000517	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—prostate cancer	0.000237	0.000505	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—prostate cancer	0.00023	0.00049	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—prostate cancer	0.000228	0.000486	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—prostate cancer	0.000226	0.000482	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—prostate cancer	0.000226	0.000481	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—prostate cancer	0.000225	0.000478	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—prostate cancer	0.000213	0.000454	CcSEcCtD
Hydroflumethiazide—CA5B—Metabolism—COMT—prostate cancer	9.08e-05	0.000295	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2C19—prostate cancer	9.07e-05	0.000295	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP19A1—prostate cancer	9.05e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—STAT3—prostate cancer	9.05e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTP1—prostate cancer	9.04e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTP1—prostate cancer	9.04e-05	0.000294	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—LPL—prostate cancer	8.96e-05	0.000291	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SULT2A1—prostate cancer	8.95e-05	0.000291	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ITPR1—prostate cancer	8.89e-05	0.000289	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ITPR1—prostate cancer	8.89e-05	0.000289	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKR1C3—prostate cancer	8.88e-05	0.000289	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ACHE—prostate cancer	8.85e-05	0.000288	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTT1—prostate cancer	8.85e-05	0.000288	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PRKACB—prostate cancer	8.83e-05	0.000287	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MED12—prostate cancer	8.8e-05	0.000286	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2A6—prostate cancer	8.75e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP17A1—prostate cancer	8.74e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GNG5—prostate cancer	8.73e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—RXRA—prostate cancer	8.73e-05	0.000284	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IL2—prostate cancer	8.69e-05	0.000282	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOA2—prostate cancer	8.69e-05	0.000282	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP1A1—prostate cancer	8.65e-05	0.000281	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ERCC2—prostate cancer	8.58e-05	0.000279	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKR1C3—prostate cancer	8.51e-05	0.000277	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PRKACB—prostate cancer	8.47e-05	0.000275	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA3—prostate cancer	8.41e-05	0.000273	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—COMT—prostate cancer	8.41e-05	0.000273	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMS—prostate cancer	8.4e-05	0.000273	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMS—prostate cancer	8.4e-05	0.000273	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP17A1—prostate cancer	8.38e-05	0.000272	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—prostate cancer	8.37e-05	0.000272	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOA2—prostate cancer	8.33e-05	0.000271	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—prostate cancer	8.3e-05	0.00027	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—prostate cancer	8.3e-05	0.00027	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC5A5—prostate cancer	8.29e-05	0.000269	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ITPR1—prostate cancer	8.24e-05	0.000268	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—LPL—prostate cancer	8.15e-05	0.000265	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—LPL—prostate cancer	8.15e-05	0.000265	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP2E1—prostate cancer	8.09e-05	0.000263	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MTHFR—prostate cancer	8.07e-05	0.000262	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HPGDS—prostate cancer	8.02e-05	0.000261	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NQO1—prostate cancer	8e-05	0.00026	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOA2—prostate cancer	7.98e-05	0.00026	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2C19—prostate cancer	7.97e-05	0.000259	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC5A5—prostate cancer	7.94e-05	0.000258	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PPARA—prostate cancer	7.91e-05	0.000257	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TH—prostate cancer	7.89e-05	0.000256	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP1A1—prostate cancer	7.87e-05	0.000256	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP1A1—prostate cancer	7.87e-05	0.000256	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ERCC2—prostate cancer	7.81e-05	0.000254	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ERCC2—prostate cancer	7.81e-05	0.000254	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP3A4—prostate cancer	7.8e-05	0.000254	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—EP300—prostate cancer	7.79e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ACHE—prostate cancer	7.78e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—prostate cancer	7.78e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMS—prostate cancer	7.78e-05	0.000253	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2E1—prostate cancer	7.76e-05	0.000252	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2A6—prostate cancer	7.69e-05	0.00025	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—prostate cancer	7.69e-05	0.00025	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1B1—prostate cancer	7.67e-05	0.000249	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NQO1—prostate cancer	7.67e-05	0.000249	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC5A5—prostate cancer	7.62e-05	0.000248	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—prostate cancer	7.58e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TH—prostate cancer	7.56e-05	0.000246	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—LPL—prostate cancer	7.55e-05	0.000245	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKR1C3—prostate cancer	7.48e-05	0.000243	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP3A4—prostate cancer	7.48e-05	0.000243	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PRKACB—prostate cancer	7.44e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2E1—prostate cancer	7.44e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CAV1—prostate cancer	7.44e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GGT1—prostate cancer	7.43e-05	0.000242	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—prostate cancer	7.38e-05	0.00024	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP17A1—prostate cancer	7.37e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NQO1—prostate cancer	7.36e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1B1—prostate cancer	7.36e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MTHFR—prostate cancer	7.34e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MTHFR—prostate cancer	7.34e-05	0.000239	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOA1—prostate cancer	7.32e-05	0.000238	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP1A1—prostate cancer	7.29e-05	0.000237	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TH—prostate cancer	7.25e-05	0.000236	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ERCC2—prostate cancer	7.23e-05	0.000235	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP19A1—prostate cancer	7.21e-05	0.000234	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PPARA—prostate cancer	7.2e-05	0.000234	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PPARA—prostate cancer	7.2e-05	0.000234	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP3A4—prostate cancer	7.17e-05	0.000233	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GGT1—prostate cancer	7.12e-05	0.000232	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1B1—prostate cancer	7.05e-05	0.000229	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA2—prostate cancer	7.02e-05	0.000228	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOA1—prostate cancer	7.02e-05	0.000228	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—RXRA—prostate cancer	6.96e-05	0.000226	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP19A1—prostate cancer	6.92e-05	0.000225	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—prostate cancer	6.9e-05	0.000224	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GGT1—prostate cancer	6.83e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MTHFR—prostate cancer	6.8e-05	0.000221	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CG—prostate cancer	6.78e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—prostate cancer	6.78e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CAV1—prostate cancer	6.77e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CAV1—prostate cancer	6.77e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOA1—prostate cancer	6.73e-05	0.000219	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—COMT—prostate cancer	6.71e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC5A5—prostate cancer	6.7e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—prostate cancer	6.68e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—RXRA—prostate cancer	6.68e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PPARA—prostate cancer	6.67e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP19A1—prostate cancer	6.63e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ITPR1—prostate cancer	6.57e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2E1—prostate cancer	6.54e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NQO1—prostate cancer	6.47e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—COMT—prostate cancer	6.43e-05	0.000209	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—INS—prostate cancer	6.41e-05	0.000209	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—RXRA—prostate cancer	6.4e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—prostate cancer	6.4e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TH—prostate cancer	6.37e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—prostate cancer	6.32e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP3A4—prostate cancer	6.31e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ITPR1—prostate cancer	6.3e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CREBBP—prostate cancer	6.28e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—prostate cancer	6.28e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CAV1—prostate cancer	6.27e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMS—prostate cancer	6.21e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1B1—prostate cancer	6.2e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CG—prostate cancer	6.17e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CG—prostate cancer	6.17e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—COMT—prostate cancer	6.16e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—prostate cancer	6.14e-05	0.000199	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—prostate cancer	6.13e-05	0.000199	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ITPR1—prostate cancer	6.04e-05	0.000196	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—LPL—prostate cancer	6.02e-05	0.000196	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GGT1—prostate cancer	6e-05	0.000195	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CD—prostate cancer	5.96e-05	0.000194	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMS—prostate cancer	5.95e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA1—prostate cancer	5.91e-05	0.000192	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—prostate cancer	5.88e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—INS—prostate cancer	5.84e-05	0.00019	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—INS—prostate cancer	5.84e-05	0.00019	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP19A1—prostate cancer	5.83e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A1—prostate cancer	5.82e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—LPL—prostate cancer	5.77e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ERCC2—prostate cancer	5.77e-05	0.000187	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CA—prostate cancer	5.77e-05	0.000187	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CREBBP—prostate cancer	5.72e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CREBBP—prostate cancer	5.72e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CG—prostate cancer	5.71e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMS—prostate cancer	5.7e-05	0.000185	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—prostate cancer	5.64e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—RXRA—prostate cancer	5.63e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NOS3—prostate cancer	5.63e-05	0.000183	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—prostate cancer	5.58e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A1—prostate cancer	5.58e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—LPL—prostate cancer	5.53e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ERCC2—prostate cancer	5.53e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTHFR—prostate cancer	5.42e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CD—prostate cancer	5.42e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CD—prostate cancer	5.42e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—COMT—prostate cancer	5.42e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—INS—prostate cancer	5.41e-05	0.000176	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—prostate cancer	5.39e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A1—prostate cancer	5.35e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PPARA—prostate cancer	5.32e-05	0.000173	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ITPR1—prostate cancer	5.31e-05	0.000173	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ERCC2—prostate cancer	5.3e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CREBBP—prostate cancer	5.3e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTHFR—prostate cancer	5.2e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CB—prostate cancer	5.19e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—prostate cancer	5.15e-05	0.000167	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NOS3—prostate cancer	5.12e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NOS3—prostate cancer	5.12e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PPARA—prostate cancer	5.1e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CD—prostate cancer	5.02e-05	0.000163	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMS—prostate cancer	5.01e-05	0.000163	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CAV1—prostate cancer	5e-05	0.000163	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTHFR—prostate cancer	4.98e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—prostate cancer	4.96e-05	0.000161	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PPARA—prostate cancer	4.89e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—LPL—prostate cancer	4.87e-05	0.000158	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CAV1—prostate cancer	4.79e-05	0.000156	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NOS3—prostate cancer	4.74e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CB—prostate cancer	4.72e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CB—prostate cancer	4.72e-05	0.000154	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—prostate cancer	4.71e-05	0.000153	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A1—prostate cancer	4.7e-05	0.000153	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—prostate cancer	4.68e-05	0.000152	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—prostate cancer	4.68e-05	0.000152	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ERCC2—prostate cancer	4.66e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CAV1—prostate cancer	4.6e-05	0.000149	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CG—prostate cancer	4.55e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—prostate cancer	4.49e-05	0.000146	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTHFR—prostate cancer	4.38e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CB—prostate cancer	4.38e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CG—prostate cancer	4.37e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—prostate cancer	4.34e-05	0.000141	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—INS—prostate cancer	4.31e-05	0.00014	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PPARA—prostate cancer	4.3e-05	0.00014	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—EP300—prostate cancer	4.28e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CREBBP—prostate cancer	4.22e-05	0.000137	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CG—prostate cancer	4.19e-05	0.000136	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—INS—prostate cancer	4.13e-05	0.000134	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—prostate cancer	4.08e-05	0.000133	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—prostate cancer	4.08e-05	0.000133	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CREBBP—prostate cancer	4.05e-05	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CAV1—prostate cancer	4.04e-05	0.000131	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CD—prostate cancer	4e-05	0.00013	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—INS—prostate cancer	3.96e-05	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—EP300—prostate cancer	3.89e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—EP300—prostate cancer	3.89e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CREBBP—prostate cancer	3.88e-05	0.000126	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CD—prostate cancer	3.84e-05	0.000125	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—prostate cancer	3.78e-05	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NOS3—prostate cancer	3.78e-05	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CG—prostate cancer	3.68e-05	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CD—prostate cancer	3.68e-05	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NOS3—prostate cancer	3.63e-05	0.000118	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—EP300—prostate cancer	3.61e-05	0.000117	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CB—prostate cancer	3.49e-05	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—INS—prostate cancer	3.48e-05	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NOS3—prostate cancer	3.48e-05	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—prostate cancer	3.46e-05	0.000112	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CREBBP—prostate cancer	3.41e-05	0.000111	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CB—prostate cancer	3.35e-05	0.000109	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—prostate cancer	3.32e-05	0.000108	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CD—prostate cancer	3.24e-05	0.000105	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CB—prostate cancer	3.21e-05	0.000104	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—prostate cancer	3.18e-05	0.000103	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CA—prostate cancer	3.17e-05	0.000103	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NOS3—prostate cancer	3.06e-05	9.93e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—prostate cancer	3.02e-05	9.8e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—prostate cancer	2.89e-05	9.4e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CA—prostate cancer	2.88e-05	9.36e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CA—prostate cancer	2.88e-05	9.36e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—EP300—prostate cancer	2.88e-05	9.35e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CB—prostate cancer	2.82e-05	9.17e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—prostate cancer	2.79e-05	9.08e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—prostate cancer	2.77e-05	9.01e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—EP300—prostate cancer	2.76e-05	8.96e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CA—prostate cancer	2.67e-05	8.67e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—EP300—prostate cancer	2.64e-05	8.59e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—prostate cancer	2.59e-05	8.41e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—prostate cancer	2.44e-05	7.92e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—prostate cancer	2.35e-05	7.65e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—prostate cancer	2.35e-05	7.65e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—EP300—prostate cancer	2.32e-05	7.55e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—prostate cancer	2.18e-05	7.08e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CA—prostate cancer	2.13e-05	6.92e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CA—prostate cancer	2.04e-05	6.63e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CA—prostate cancer	1.96e-05	6.36e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—prostate cancer	1.74e-05	5.65e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CA—prostate cancer	1.72e-05	5.59e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—prostate cancer	1.67e-05	5.42e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—prostate cancer	1.6e-05	5.19e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—prostate cancer	1.4e-05	4.57e-05	CbGpPWpGaD
